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Background. Hypothalamic-pituitary-adrenocortical (HPA) axis abnormalities have been found in patients with
a psychotic disorder and first-degree relatives of patients with a psychotic disorder react with subtle increases in
non-clinical psychotic experiences and negative emotions in the face of everyday stress. The current study in-
vestigated whether HPA axis functioning is altered in individuals at above average genetic risk for psychotic
disorder, examining diurnal cortisol profiles, cortisol reactivity to daily stressors and the association between HPA
axis activity and subclinical psychotic experiences.
Method. Participants included siblings of patients with a psychotic disorder (n=60) and a healthy comparison group
(n=63). The Experience Sampling Method (a structured diary technique) was employed to assess stress, psychotic
experiences, negative affect and salivary cortisol repeatedly in the flow of daily life.
Results. Multi-level analyses revealed higher diurnal cortisol levels and heightened cortisol reactivity to negative
daily events in siblings compared with controls. Diurnal cortisol slope did not differ between the two groups, but
momentary increases in psychotic experiences and negative affect were associated with increased cortisol in the
sibling group.
Conclusions. Findings support altered HPA axis activity in individuals at above average genetic risk for psychotic
disorder, as evidenced by higher diurnal cortisol levels and increased cortisol reactivity to daily stress. Results also
suggest a dynamic association between cortisol secretion and the intensity of psychotic-like experiences and negative
emotions in daily life, although the direction of this association remains to be elucidated.
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Introduction
Minor stresses in the flow of daily life have repeatedly
been associated with increases in psychotic symptoms
and negative emotions in individuals with a psychotic
disorder (Myin-Germeys et al. 2005a). However, the
biological substrate underlying this phenomenon re-
mains unknown and vulnerability markers need to be
identified. Results of experimental studies suggest
that increased psychotic reactivity to stress may reflect
increased dopamine reactivity (Myin-Germeys et al.
2005b ; Soliman et al. 2008). In addition, several lines
of evidence indicate that dysregulation of the
hypothalamic-pituitary-adrenocortical (HPA) axis
may play a role in the relationship between stress and
psychotic experiences (van Winkel et al. 2008 ; Walker
et al. 2008). In individuals with a psychotic disorder,
abnormalities have been found at various levels of the
HPA axis, including functional and structural changes
in the hypothalamus (Koolschijn et al. 2008), the pitu-
itary (Pariante, 2008) and the hippocampus (Wright
et al. 2000). Similarly, cortisol levels and reactivity to
stress may be disturbed (Albus et al. 1982 ; Breier et al.
1988 ; Jansen et al. 1998 ; Jansen et al. 2000 ; Marcelis
et al. 2004 ; Ryan et al. 2004 ; Walsh et al. 2005 ; Brenner
et al. 2009 ; Mondelli et al. 2010). Nevertheless, it re-
mains uncertain whether HPA axis abnormalities are
causally related to the increased emotional and psy-
chotic stress reactivity observed in patients with a
psychotic disorder.
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One of the major obstacles to research in this area is
that patients with a psychotic disorder usually receive
antipsychotic medication, which can affect cortisol
levels and brain structures (Meltzer et al. 1989 ; Wik,
1995 ; Pariante, 2008). Thus, studies in patient samples
cannot yield firm conclusions about HPA axis dysre-
gulation as a biological substrate or vulnerability
marker. Studies in patients with a first episode of
psychotic illness are informative in that they are not
confounded by long-term medication or illness effects.
However, they cannot establish the degree to which
increased HPA axis activity constitutes a precursor of
psychosis, as reflected in an increased vulnerability to
stress, as opposed to being the result of the psychosis
and related stress. Therefore, studies have been con-
ducted in persons who are prone to psychosis but
have not developed a psychotic disorder. Schizotypal
adolescents, for example, were found to have higher
cortisol levels than controls (Mittal et al. 2007) and
heightened cortisol secretion in another sample of
schizotypal adolescents was associated with schizoty-
pal symptomatology at 2-year follow-up (Walker et al.
2001). The potential predictive value of HPA axis
abnormalities is further supported by findings in a
sample of young people at ultra-high risk of psychotic
disorder ; months before onset, those who later devel-
oped a psychotic disorder had larger pituitary
volumes than those who did not develop a disorder
(Garner et al. 2005). Walker et al. (2010) recently re-
ported that higher cortisol levels predicted higher
risk of conversion to psychotic disorder in an at-risk
sample studied longitudinally. Together, these find-
ings add support to the hypothesis that heightened
stress reactivity may be one of the risk factors under-
lying both HPA axis abnormalities and vulnerability
to psychotic disorder.
Healthy siblings of individuals with a psychotic
disorder are another important research population:
they share not only genetic vulnerability for psychosis
with their affected siblings, but also many socio-
demographic, parental and developmental charac-
teristics. First-degree relatives show increases in the
intensity of subtle psychotic experiences and negative
emotions in reaction to daily hassles (Myin-Germeys
et al. 2001b, 2005a). Moreover, studies have reported
structural HPA axis abnormalities, such as increased
pituitary (Mondelli et al. 2008) and hypothalamic
volumes (Goldstein et al. 2007), in relatives of patients
with schizophrenia. However, sibling studies have not
yet examined cortisol secretory patterns or the poss-
ible association of cortisol with increased emotional
and psychotic reactivity to stress in daily life.
The current study, therefore, assessed cortisol in
a sample of siblings of patients with psychotic dis-
order and matched controls. We used the Experience
Sampling Method (ESM), a structured diary tech-
nique, to assess daily hassles, psychotic experiences
and negative emotions at frequent intervals over the
course of several days, with concurrent sampling of
salivary cortisol. In studies conducted in the natural
environment, cortisol is generally characterized in
terms of overall levels, diurnal patterns and reactivity
to acute stressors (Nicolson, 2007). Cortisol has a pro-
nounced circadian rhythm, with a sharp increase in
the first hour after awakening and a gradual decrease
over the rest of the day. Acute stressors can induce
short-term peaks, with a half-life of approximately 1 h.
The design of the current study allowed investigation
of several of these aspects of cortisol secretion. The
aims were threefold: (i) to examine differences in
overall cortisol levels and diurnal slope between
siblings and controls ; (ii) to investigate differences
between siblings and controls in cortisol reactivity in
response to naturally occurring stressors ; (iii) to de-
termine the association between momentary psychotic
experiences or negative emotions and momentary
cortisol in siblings compared with controls. In case
of significant group differences, we performed ad-
ditional analyses to explore alternative (non-genetic)
explanations of any difference in cortisol patterns
(including effects of depression, childhood trauma,
current stress and distress levels and degree of
psychometric psychosis liability).
Method
Participants
The sample consisted of 71 healthy siblings (68 full
siblings and three half-siblings) of patients diagnosed
with a non-affective psychotic disorder and 66 control
subjects. The siblings were recruited through their ill
relatives or family support organizations as part of a
larger study (G.R.O.U.P., 2010). Controls were selected
through random mailings to addresses in the residen-
tial areas of patients and siblings. Written informed
consent, conforming to local ethics committee guide-
lines, was obtained from all subjects. The Compre-
hensive Assessment of Symptoms and History
(Andreasen et al. 1992) was completed to assess
symptom history over the past 6 months and lifetime,
yielding DSM-IV diagnoses (APA, 1994). Inclusion
criteria were : (i) age 16–55 years ; (ii) sufficient com-
mand of the Dutch language. Exclusion criteria were :
(i) use of steroid medication ; (ii) current Axis 1 dis-
order ; (iii) lifetime history of psychotic disorder ;
and, for the controls, (iv) family history of psychotic
disorder as assessed by the FIGS (NIMH Genetics
Initiative, 1992).
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ESM
The ESM is a random time-sampling self-assessment
technique; studies have demonstrated the feasibility,
validity and reliability of ESM in general and patient
populations (Csikszentmihalyi & Larson, 1987; Myin-
Germeys et al. 2009). Subjects received a digital wrist-
watch that emitted a signal 10 times per day on six
consecutive days, at unpredictable moments between
07:30 and 22:30 hours. After each ‘beep’, subjects
completed ESM self-assessment forms concerning
current context, thoughts, emotions and psychotic ex-
periences. Subjects were instructed to complete their
reports immediately after the beep, thus minimizing
memory distortions. Reports were considered valid
when subjects responded within 15 min after the beep,
as determined by comparing the actual beep time with
the reported time of completion. For inclusion in the
analyses, participants had to have provided valid re-
sponses to at least one-third of the emitted beeps
(Delespaul et al. 2002).
Salivary cortisol sampling
After each ESM beep, subjects collected a saliva
sample with a cotton swab (Salivette ; Sarstedt, The
Netherlands), replaced the swab in the salivette tube,
and recorded the exact collection time. Samples were
stored in subjects’ home freezers until transport to
the laboratory, where uncentrifuged samples were
kept atx20 xC until analysis. Saliva samples collected
more than 15 min after the beep were excluded from
the analysis.
ESM measures
Event stress
Stress was conceptualized in terms of subjective
appraisals of events and minor disturbances that
continually occur in the natural flow of daily life. After
each beep, participants were asked to report the most
important event that had happened between the
current and the previous report and then to rate this
event on a 7-point, bipolar Likert scale (x3=very un-
pleasant, 0=neutral, 3=very pleasant). For the cur-
rent analyses, all positive responses were recoded as 0
and the negative responses were recoded so that high
scores reflect more unpleasant and potentially stress-
ful events (0=neutral, 3=very unpleasant) (Jacobs
et al. 2007).
Psychotic experiences
Psychotic symptomatology was assessed with eight
ESM items rated on 7-point Likert scales (1=not at
all to 7=very) : ‘My thoughts are now paranoid’,
‘My thoughts are difficult to express ’, ‘ I can’t get rid
of my thoughts ’, ‘My thoughts are influenced by other
people ’, ‘ I feel unreal ’, ‘ I hear voices ’, ‘ I see things’
and ‘I am afraid of losing control ’ (Myin-Germeys
et al. 2005a). The mean of these eight ratings formed
the variable psychotic experiences.
Negative affect
Negative affect was assessed as the mean score on five
ESM items, rated on 7-point Likert scales (1=not at all
to 7=very) : ‘ I feel insecure ’, ‘ I feel lonely ’, ‘ I feel an-
xious ’, ‘ I feel down’ and ‘I feel guilty ’.
Salivary cortisol
Salivary cortisol is a reliable and non-invasive
measure of the free, unbound cortisol in blood,
which is considered to be the biologically active hor-
mone. Radio-immunoassays were run in duplicate,
using a tracer solution of cortisol-3CMO coupled with
2-[125 I]histamine and specific antibodies raised against
cortisol-3CMO-BSA (Sulon et al. 1978) (Dr J. Sulon,
University of Lie`ge). The lower detection limit of the
assay was 0.2 nmol/l. The intra- and inter-assay coef-
ficients of variation were <5% and <12%, respect-
ively. All samples from an individual were analysed
in the same assay to reduce sources of variability.
Observations with cortisol >44 nmol/l (n=11) were
considered physiologically abnormal and were ex-
cluded from the statistical analysis (van Eck et al. 1996;
Peeters et al. 2004 ; Jacobs et al. 2007).
Questionnaire measures
Trait psychosis liability
Participants completed the 40-item Community
Assessment of Psychic Experiences (CAPE) (Hanssen
et al. 2005), a self-report instrument that captures
variation in the positive and negative dimensions of
non-clinical psychotic experiences as well as variation
in depression. The total score on the positive dimen-
sion (hereafter CAPE trait score) was used as indicator
of psychometric psychosis liability.
Childhood trauma
Participants completed a Dutch version of the
Childhood Trauma Questionnaire 25-item short
form (CTQ) (Bernstein et al. 2003). The CTQ consisted
of 25 questions rated on a 5-point Likert scale enquir-
ing about traumatic experiences in childhood. A gen-
eral measure of childhood trauma was generated
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by calculating the sum of the answers to all 25
questions.
Statistical analyses
Multi-level modelling approach
Analyses of variance and x2 tests were conducted to
investigate group differences in demographic charac-
teristics, cross-sectional measures and mean ratings on
ESM variables. ESM and cortisol data were analysed
using multi-level regression techniques, which take
the hierarchical structure of the data into account.
Altogether, 35 families provided more than one par-
ticipant, resulting in a further level of clustering. Thus,
in the current study, repeated momentary measure-
ments (level 1) were clustered within days (level 2),
within subjects (level 3), some of whomwere members
of the same family (level 4). Data were analysed using
the XTMIXED multi-level random regression routine in
Stata 11.0 (StataCorp, 2009). The b’s are the fixed re-
gression coefficients of the predictors in the multi-level
model. When significant interactions were found,
stratified analyses were conducted to clarify group
differences, using the STATA LINCOM command to cal-
culate the appropriate linear combinations.
Cortisol values were log transformed to reduce
skewness of distribution, generating the variable
lncort. The variable time was centred around the
grand mean for all samples. To model the cortisol di-
urnal curve, the variables time and time2 were in-
cluded as predictors in all analyses, with lncort as
dependent variable ; addition of higher order poly-
nomial terms did not improve model fit. The following
confounders were examined in all models : gender ;
age ; recent consumption of food or tobacco use (i.e. in
the approximately 90 min interval since the previous
ESM beep) ; use of oral contraceptives ; recent awak-
ening (samples taken within 60 min of awakening).
Cortisol levels and diurnal slope
To test whether mean cortisol level differed between
sibling and control groups, a multi-level model
was estimated with lncort as the dependent variable
and the categorical variable group (0=controls,
1=siblings) as independent variable. To examine
whether familial vulnerability for psychosis was re-
flected in the diurnal cortisol slope, a grouprtime in-
teraction term was added to the model.
Cortisol reactivity to daily stressors
To investigate whether stress elicited differential cor-
tisol reactions in the two groups, a multi-level analysis
was conducted with lncort as the dependent variable
and group, event stress and their interaction as the
independent variables.
Association between cortisol, psychotic experiences and
negative affect
To examine whether increases in psychotic experi-
ences or negative affect were associated with within-
person fluctuations in cortisol, we first conducted
multi-level analyses with lncort as the dependent
variable and group, psychotic experiences (and re-
spectively negative affect) and their interaction as
the independent variables. Next, negative affect and
psychotic experiences and their interactions with
group were included in the same model to determine
whether negative affect might mediate the relationship
betweenmomentary psychotic experience and cortisol,
given that negative emotions have been associated
with both cortisol and psychosis (Myin-Germeys
et al. 2001a ; Freeman & Garety, 2003 ; Thompson
et al. 2007).
Results
Compliance and sample characteristics
Altogether, 14 participants (11 siblings and three con-
trol subjects) were unable to comply adequately with
the research protocol (13 filled in fewer than 20 valid
reports and one provided no saliva samples) and were
therefore excluded from the analyses. The final sample
included 123 participants (60 siblings and 63 controls),
who completed a total of 5217 valid ESM observations.
Control group participants completed significantly
more ESM reports than the siblings [mean (S.D.)=45.6
(8.6) and 41.0 (9.3) reports, respectively ; F=8.31,
p=0.01]. Sample characteristics are summarized
in Table 1. Sibling and control groups were well mat-
ched on demographic variables, but controls were on
average 4.5 years older. With the exception of moder-
ate differences in ESM compliance and age, the two
groups did not differ significantly from each other on
any of the displayed variables.
Cortisol levels and diurnal slope
Siblings had significantly higher cortisol levels over
the ESM sampling moments than controls (Table 2).
This pattern was present throughout the day, with no
difference between the two groups in the steepness of
the diurnal decline in cortisol secretion, as evidenced
by the non-significant grouprtime of day effect
shown in Table 2.
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Cortisol reactivity to daily stress
Controls and siblings reported similar frequencies and
intensities of daily negative events [mean (S.D.)=14.5
(12.3) and 13.1 (10), respectively ; F=0.49, p=0.49].
There was no significant interaction between group
and event stress in the model of negative affect
[x2(1)=0.03, p=0.87], but a main effect of event stress
[b=0.11, 95% confidence intervals (CI) 0.087–0.122;
p<0.001]. Multi-level analysis confirmed the main ef-
fect of group on cortisol (b=0.17, 95% CI 0.016–0.316,
p=0.03) but revealed no main effect of event stress
(b=0.01, 95% CI –0.013 to 0.034 ; p=0.37). However,
there was a significant interaction between group and
event stress [x2(1)=4.11, p=0.04]. Stratified analyses
showed an increase in cortisol following unpleasant
events in the siblings (b=0.04, 95% CI 0.003–0.075,
p=0.03), but no such effect in the controls (b=x0.01,
95% CI x0.04 to 0.021 ; p=0.53) (Fig. 1). Controlling
for negative affect, a putative mediator of the stress–
cortisol relationship, had no substantial effect on the
results [grouprevent stress interaction : x2(1)=4.71,
p=0.03].
Association between cortisol, psychotic experiences
and negative affect
There was no main effect of psychotic experiences on
momentary cortisol. However, group moderated the
effect of psychotic experiences on cortisol (Table 3,
Table 1. Demographic characteristics and descriptives
Controls (n=63) Siblings (n=60)
Group comparisons
Test statistic p value
Age, years : mean (S.D.) 33.27 (10.3) 28.82 (10.0) F=5.93 0.02
Gender (male : female) 18 :45 22 :38 x2(1)=0.98 0.34
Education, n (%)a x2(1)=2.53 0.11
Secondary school or less 20 (31.8%) 27 (45.8%)
Higher education 43 (68.3%) 32 (54.2%)
Marital status, n (%)a x2(1)=1.31 0.25
Married or living together 39 (61.9%) 31 (51.7%)
Never married/single/divorced 24 (38.2%) 29 (48.4%)
Work situation, n (%)a x2(1)=1.34 0.51
Working/significant housework/studying 61 (98.8%) 58 (96.7%)
Disabled or unemployed 2 (3.2%) 2 (3.3%)
Living situation, n (%)a x2(4)=7.85 0.10
Alone 7 (11.1%) 3 (5%)
With partner/family/children 43 (68.3%) 33 (55%)
With parents/relatives 10 (15.9%) 20 (33.3%)
Other 3 (4.8%) 4 (6.7%)
CASH DSM-IV Axis I diagnosis lifetime, n (%)a x2(2)=1.56 0.46
Depressive disorder, in partial remission 3 (4.8%) 1 (1.7%)
Depressive disorder, in full remission 8 (12.7%) 11 (18.3%)
No diagnosis 52 (82.5%) 48 (80%)
CAPE trait score, mean (S.D.) 1.0 (0.14) 1.1 (0.21) F=2.04 0.16
CTQ abuse, total score (S.D.) 33.13 (7.71) 33.57 (8.43) F=0.09 0.76
Current smoker (no :yes) 49 :14 43 :17 x2(1)=0.61 0.44
Current cannabis user (no :yes) 61 :2 57 :3 x2(1)=0.26 0.61
ESM variables
Event stress, meanb (S.D.) 0.21 0.17 F=1.38 0.24
Psychotic experiences, meanb (S.D.) 1.1 (0.16) 1.1 (0.17) F=0.09 0.78
Negative affect, meanb (S.D.) 1.23 (0.28) 1.21 (0.34) F=0.09 0.76
Momentary cortisol, meanb nmol/l (S.D.) 2.91 (0.15) 3.56 (0.22) F=5.98 0.02
CASH, Comprehensive Assessment of Symptoms and History (Andreasen et al. 1992) ; CAPE, Community Assessment of
Psychic Experiences ; CTQ, Childhood Trauma Questionnaire ; ESM, Experience Sampling Method.
a Due to rounding, percentages may not add exactly to 100%.
b For the experience sampling variables, an individual mean was first calculated over all reports ; these values were then
aggregated to obtain the group mean and S.D.
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Model 1). In the sibling group, increased levels of
momentary psychotic experiences were associated
with increased cortisol levels (b=0.18, 95% CI 0.081–
0.287 ; p<0.001), whereas in the control group, no as-
sociation was found between psychotic experiences
and cortisol (b=x0.02, 95% CI x0.105 to 0.075;
p=0.74). For negative affect, there was no main effect
in the model predicting cortisol ; however, an interac-
tion was found with group (Table 3, Model 2).
Stratified analyses indicated no significant association
between negative affect and cortisol in the control
group, whereas in the sibling group cortisol levels in-
creased when participants reported higher negative
affect. Finally, in a full model that included group,
psychotic experiences, negative affect and the interac-
tions between group and the two ESM variables, only
the interaction between group and psychotic experi-
ences remained significant (Table 3, Model 3).
Post-hoc exploratory analyses
To better understand the nature of the observed dif-
ferences in cortisol patterns between sibling and
control groups, we conducted a final series of multi-
level analyses exploring the possible contribution
of depression (presence or absence of lifetime diag-
nosis), childhood trauma (CTQ total score), overall
current stress (mean unpleasantness of daily events
during the sampling week) and distress (mean nega-
tive affect level) and degree of psychometric psy-
chosis liability (CAPE trait score), by either exploring
the interaction with group or adding the appropriate
variable as additional predictor in the models of
cortisol. Apart from some small effect size alterations,
results were similar, with siblings having significantly
higher cortisol levels over the ESM sampling
moments and a significantly increased cortisol re-
sponse following unpleasant events compared with
controls. Some minor decrease of significance
emerged only in the analyses controlling for psycho-
metric psychosis liability [effect of group on cortisol :
b=0.15, 95% CI x0.003 to 0.305; p=0.05 ; interaction
between group and event stress on cortisol : x2(1)=
3.49, p=0.06].
Sensitivity analysis in non-depressed participants
Additional analyses were carried out, investigating
whether diagnoses of depression impacted the
results. All analyses were repeated with exclusion of
participants who had a current or past diagnosis
of depression (controls n=52 and relatives n=48 re-
mained in the analyses). The results remained the
same.
Table 2. Multi-level regression estimates for effects of group on cortisol level and diurnal slope
b 95% CI S.E. Z p
Intercept 1.137 0.780 to 1.494 0.182 6.25 <0.001
Group 0.169 0.019 to 0.319 0.076 2.21 0.027
Time of day (diurnal slope) x0.130 x0.134 tox0.125 0.002 x54.43 <0.001
Grouprtime of day x0.003 x0.009 to 0.004 0.003 x0.85 0.393
Age x0.009 x0.017 tox0.002 0.004 x2.55 0.011
Gender x0.181 x0.338 tox0.024 0.079 x2.27 0.023
Oral contraceptives 0.155 x0.015 to 0.325 0.087 1.79 0.074
Recent awakening 0.330 0.269 to 0.391 0.031 10.63 <0.001
Recent food intake 0.161 0.128 to 0.193 0.016 9.77 <0.001
Recent smoking 0.124 0.045 to 0.203 0.040 3.08 0.002
The dependent variable is log-transformed cortisol (lncort). Regression coefficients are unstandardized. Group is coded 1
for siblings and 0 for controls. The variable time of day is centred around the grand mean. Time2 was also a significant
predictor of lncort (p<0.001) and is controlled for in all analyses. Recent awakening refers to samples taken within 60 min
after awakening ; recent food intake and smoking refer to reported occurrence of these activities in the interval between two
Experience Sampling Method reports (roughly 90 min).
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Fig. 1. Cortisol reactivity to stressful events. Modelled change
(based on regression coefficient) in untransformed cortisol
values (nmol/l) following daily events, according to their
appraised unpleasantness (0=neutral, 3=very unpleasant),
in sibling (sibs) and control groups.
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Discussion
The current findings indicated that siblings of in-
dividuals with psychotic disorder had higher mean
cortisol levels throughout the day and greater cortisol
reactivity to daily stressors than a comparison group
with no family history of psychosis. In the sibling
but not the control group, rated intensities of mo-
mentary psychotic experiences and negative emotions
were associated with transient increases in cortisol
secretion. These findings suggest that alterations in
HPA axis activity previously reported in patients with
established psychotic disorder, unmedicated first-
episode patients, and ultra-high risk samples may
also be present to some degree in healthy first-degree
relatives.
The higher diurnal cortisol observed in the sibling
group is consistent with reports of elevated HPA ac-
tivity in patients with schizophrenia (Muck-Seler
et al. 2004), first-episode psychosis (Ryan et al. 2004 ;
Mondelli et al. 2010) and individuals at high risk for
psychotic disorder (Mittal et al. 2007; Walker et al.
2010). However, other studies suggest a blunted cor-
tisol response to stress in chronic and first episode
psychosis (Jansen et al. 2000; van Venrooij et al. 2010).
Together, these findings may support the notion that
altered activity of the HPA axis may be a marker of
underlying vulnerability for psychotic disorder. The
finding of greater cortisol reactivity to daily stressors
in siblings compared with controls provides new in-
formation, in light of the fact that previous studies
of neuroendocrine responses to stress in psychotic
disorder or at-risk samples were performed in the
laboratory. In the control group, we expected to find
relatively smaller cortisol stress reactivity to stress
compared with the sibling group. In the current study,
stressors were daily hassles and minor disturbances in
the flow of everyday life. In comparison with exper-
imentally induced stress, these were insufficiently
stressful to influence cortisol secretion in our control
group, without underlying vulnerability for psychotic
disorder. The cortisol non-response in our control
group may be a sign of good psychological health,
with small daily events not significantly impacting on
their stress axis. We have, however, no information
about the immediate cortisol response after stressful
events and can therefore not eliminate the possibility
of an immediate but transient cortisol response with a
short recovery time in the control group. Consistent
with findings in ESM studies of increased emotional
and psychotic symptom reactivity to minor daily
stressors in relatives of patients with psychotic dis-
order (Myin-Germeys et al. 2005a, b), the current study
reveals a similar pattern with regard to cortisol re-
sponses in the sibling group, supporting the idea that
elevated biological stress sensitivity may be a vulner-
ability marker for psychosis. However, in contrast
with the previous studies, the siblings did not differ
from controls in their emotional reactivity to daily life
stress. The current siblings may thus represent a rela-
tively healthy subgroup with ‘normal ’ levels of
emotional stress reactivity, with increased cortisol re-
sponse to daily hassles possibly reflecting a protective
mechanism.
Another potentially important finding is that mo-
mentary increases in psychotic symptomatology were
accompanied by increases in cortisol. This association
between cortisol and momentary psychotic experi-
ences can be interpreted in two causal directions. One
plausible interpretation is that the distress associated
with psychotic experiences and negative emotions
could induce secondary increases in cortisol levels.
Several studies have shown that momentary psychotic
experiences are related to increases in negative affect
Table 3. Multi-level estimates of the effects of momentary psychotic experiences and
negative affect on cortisol, as moderated by group (siblings v. controls)
b (S.E.)
Model 1 Model 2 Model 3
Intercept 1.12 (0.19)*** 1.09 (0.18)*** 1.10 (0.19)***
Group x0.05 (0.11) 0.05 (0.09) x0.08 (0.11)
Negative affect 0.02 (0.03) 0.02 (0.03)
Grouprnegative affect 0.10 (0.04)** 0.07 (0.04)
Psychotic experience x0.02 (0.05) x0.03 (0.5)
Grouprpsychotic experience 0.20 (0.07)** 0.15 (0.08)*
b, Unstandardized regression coefficient ; S.E., standard error.
The dependent variable is lncort. The models control for time, time2, age, gender,
oral contraceptive use, recent awakening, recent food intake and recent smoking.
* p<0.05, ** p<0.01, *** p<0.001.
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(Myin-Germeys et al. 2001a ; Freeman & Garety, 2003 ;
Thewissen et al. 2010). Increases in momentary nega-
tive affect have, in turn, been linked to heightened
cortisol secretion in healthy individuals (van Eck et al.
1996 ; Jacobs et al. 2007). In the current analyses, the
estimated grouprpsychotic experiences interaction
effect on cortisol decreased only slightly and remained
significant after addition of negative affect and the
grouprnegative affect interaction as predictors. In
contrast, there was no significant association between
negative affect and cortisol in this complete model.
This suggests that subclinical psychotic experiences
may have made a greater contribution than negative
affect to increased cortisol levels in the sibling group.
A second interpretation of the observed association
between cortisol and momentary psychotic experi-
ences reflects the possibility that increases in cortisol
are either directly involved in the pathogenesis of
psychotic experiences or reflect secondary, down-
stream processes. For instance, cortisol secretion in-
creases dopamine activity in certain brain regions
(Dallman et al. 2004). The dopaminergic system is
thought to play an important role in the pathogenesis
of positive psychotic symptoms (Laruelle & Abi-
Dargham, 1999). Thus, heightened cortisol secretion
could theoretically, via dopaminergic pathways, in-
crease the likelihood of clinical psychotic experiences.
The current finding could be interpreted as evidence
for a similar association with subclinical psychotic
experiences in unaffected first-degree relatives, but
whether this association is causal cannot be estab-
lished in an ESM study. In general, the observed in-
terrelationships among cortisol, psychotic experiences
and negative emotions need to be further explored in
longitudinal or experimental designs. Studies that ei-
ther induce stress and measure subsequent changes in
psychotic symptoms and emotions or that induce
psychotic experience and subsequent changes in cor-
tisol are needed to answer the question of causality
more conclusively.
Dysregulation of the HPA axis is unlikely to be
specific for psychosis, as it is found in many disorders,
in particular major depression. Moreover, cortisol lev-
els have been found to reflect depression and anxiety,
but not psychotic symptoms, in a sample at ultra-high
risk for psychosis (Thompson et al. 2007). Post-hoc
analyses therefore examined whether a history of
depression might explain the results ; however, mod-
els that controlled for previous depressive episodes
yielded similar findings. Alternatively, because sib-
lings share not only genes but also the early rearing
environment, childhood adversity – which has been
associated with both psychotic disorder (Read et al.
2005) and HPA axis abnormalities (de Bellis et al. 1994 ;
Tarullo & Gunnar, 2006) – could also have influenced
the current results. Although the two groups did not
differ in self-reported childhood maltreatment, we
also conducted post-hocmulti-level analyses to rule out
the possibility that group differences in cortisol levels
or reactivity were due to differential susceptibility to
childhood abuse. These models revealed no associ-
ation between abuse measures and cortisol in either
of the two groups. Another set of analyses examined
whether higher cortisol in the siblings might be due to
greater overall current stress or distress. This was not
the case. Finally, we found that overall psychometric
psychosis liability did not significantly influence
differences in cortisol patterns between control and
sibling groups. Thus, in line with recent findings
of cortisol abnormalities in first-episode psychosis,
which could not be explained by stressful events,
perceived stress or childhood trauma (Mondelli et al.
2010), the current results suggest that increased HPA
axis activity may indeed reflect the underlying vul-
nerability to psychosis. The biological processes in-
volved, however, remain to be elucidated.
This study has several limitations. First, use of ESM
booklets instead of electronic devices means that
the exact timing of participants’ self-reports and saliva
samples cannot be firmly established (Stone et al.
2002). However, results of a study comparing self-
reported and electronically monitored saliva collection
times, with the same intensive, semi-random time-
sampling protocol used in the current study, indicated
that saliva was generally collected very close to the
prescribed time and that self-reported collection times
corresponded well with the electronic time stamps
(Jacobs et al. 2005). Another comparative study con-
cluded that paper and electronic diaries yield similar
results (Green et al. 2006). Second, no saliva samples
were taken at the time of awakening, so that the cur-
rent dataset does not allow examination of the cortisol
awakening response, a measure of HPA axis activity
that appears to be blunted in first-episode psychosis
(Mondelli et al. 2010). Third, this study focused solely
on the circulating hormone cortisol and can thus pro-
vide no insight into underlying mechanisms at higher
levels of the HPA axis. Fourth, the interval between
cortisol sampling and event occurrence is relevant
(van Eck et al. 1996). However, there is no reason to
expect systematic differences between groups on the
time interval between stressor and time of sampling.
Therefore, we are confident that variability in time
lag does not question the validity of our analysis on
group differences. Moreover, a potentially stressful
event could have occurred between 15 and 90 min
before sampling of cortisol. As the half-life of cortisol
is about 1 h, we still expect to find traces of potential
stressors, even when they occurred some time ago.
Finally, caution is warranted in generalizing results
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from the current adult sibling sample to other groups
at increased genetic risk for psychosis. Compared with
children of parents with a psychotic disorder and
others identified as being at ultra-high risk for de-
veloping a disorder, the siblings included in this study
were older ; in most cases, past the age when onset of
psychosis is most likely to occur. The nature and ex-
tent of HPA axis abnormalities in healthy siblings may
differ from those described in at-risk and ultra-high
risk adolescent samples. Therefore, it cannot be elim-
inated that the increased cortisol reactivity in our sib-
ling group reflects a protective rather than a risk
factor. On the other hand, it might be that even with a
suboptimal biological reactivity, siblings manage to
cope better with stress and/or have other resilience
factors protecting them from psychotic disorder.
The current study also had some specific strengths.
In particular, the repeated sampling of salivary cor-
tisol over 6 days takes into account the well-known but
often ignored unreliability of cortisol measures ob-
tained at infrequent intervals (Hruschka et al. 2005).
Multiple cortisol measures per person were comp-
lemented by a relatively large number of participants.
Use of multi-level modelling allowed assessment of
within-person associations between cortisol and sub-
jective experience in real time and real-life contexts.
Although cortisol measures in both groups were
within the normal range, intensive sampling revealed
a consistent pattern of heightened HPA activity in the
siblings. Taken together, the current findings lend ad-
ditional credence to the hypothesis that irregularities
in HPA axis activity are involved in psychosis vul-
nerability, broadening the spectrum of vulnerability to
include siblings without demonstrable psychometric
risk markers.
Appendix. Genetic Risk and Outcome in Psychosis
(G.R.O.U.P.) investigators
R. S. Kahn, D. H. Linszen, J. van Os, D. Wiersma,
R. Bruggeman, W. Cahn, L. de Haan, L. Krabbendam,
I. Myin-Germeys.
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